(Q53450729)
Statements
Motexafin gadolinium for the treatment of metastatic renal cell carcinoma: phase II study results. (English)
Robert J Amato
Jaroslaw Jac
Joan Hernandez-McClain
1 September 2008
6
2
73-78
scientific article published in September 2008
No description defined